Mostrando 4 resultados de: 4
Subtipo de publicación
Article(4)
Publisher
European Journal of Clinical Pharmacology(1)
Journal of Neurology Neurosurgery and Psychiatry(1)
Oncology(1)
Pharmacology & Toxicology(1)
Área temáticas
Enfermedades(3)
Farmacología y terapéutica(2)
Fisiología humana(2)
Fisiología y materias afines(1)
Medicina y salud(1)
Origen
scopus(4)
Frequency of S-mephenytoin hydroxylation deficiency in 373 spanish subjects compared to other Caucasian populations
ArticleAbstract: We have investigated the prevalence of poor metabolisers (PM) of S-mephenytoin in 373 unrelated, heaPalabras claves:caucasian, drug metabolism, Mephenytoin, pharmacogenetics, Phenotype, polymorphismAutores:Adrián LLerena, Benitez Rodriguez J., Bertilsson L., Carrillo J.A., Reviriego J., Valdivielso M.J.Fuentes:scopusOxidative polymorphism of debrisoquine in Parkinson's disease
ArticleAbstract: Oxidative phenotype and metabolic ratio (MR) of debrisoquine (DBQ) have been determined in 87 patienPalabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Cobaleda J., Jimenez-Jimenez F.J., Ladero J.M., Martínez C., Muñoz J.J., Puerto A.M., Valdivielso M.J.Fuentes:scopusReproducibility over Time of Mephenytoin and Debrisoquine Hydroxylation Phenotypes
ArticleAbstract: Mephenytoin and debrisoquine hydroxylation phenotypes were determined twice in 15 Spanish healthy voPalabras claves:Autores:Adrián LLerena, Benitez Rodriguez J., Bertilsson L., Valdivielso M.J.Fuentes:scopusPolymorphic oxidation of debrisoquine in women with breast cancer
ArticleAbstract: Oxidative polymorphism of debrisoquine (DBQ) was determined in 98 women with breast cancer (mean agePalabras claves:Breast Cancer, debrisoquine, OXIDATION, Oxidative polymorphismAutores:Adrián LLerena, Benitez Rodriguez J., Jara C., Ladero J.M., Muñoz J.J., Valdivielso M.J., Vargas E.Fuentes:scopus